GLAXOSMITHKLINE FDA Approval ANDA 064033

ANDA 064033

GLAXOSMITHKLINE

FDA Drug Application

Application #064033

Application Sponsors

ANDA 064033GLAXOSMITHKLINE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 1GM BASE/VIAL0CEFAZOLIN SODIUMCEFAZOLIN SODIUM

FDA Submissions

ORIG1AP1993-10-31
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-05-08
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1998-05-28
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2002-07-31
LABELING; LabelingSUPPL7AP2005-01-28

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL6Null0

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 64033
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFAZOLIN SODIUM","activeIngredients":"CEFAZOLIN SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFAZOLIN SODIUM","submission":"CEFAZOLIN SODIUM","actionType":"EQ 1GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.